KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Revenue (2020 - 2025)

Oscar Health (OSCR) has disclosed Revenue for 6 consecutive years, with $2.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 19.62% year-over-year to $2.8 billion, compared with a TTM value of $11.7 billion through Dec 2025, up 30.43%, and an annual FY2025 reading of $11.7 billion, up 30.43% over the prior year.
  • Revenue was $2.8 billion for Q4 2025 at Oscar Health, down from $3.1 billion in the prior quarter.
  • Across five years, Revenue topped out at $3.1 billion in Q3 2025 and bottomed at -$4.3 billion in Q4 2023.
  • Average Revenue over 5 years is $1.1 billion, with a median of $1.7 billion recorded in 2021.
  • Peak annual rise in Revenue hit 281654.96% in 2022, while the deepest fall reached 258.1% in 2022.
  • Year by year, Revenue stood at $1.8 billion in 2021, then tumbled by 258.1% to -$2.9 billion in 2022, then tumbled by 47.21% to -$4.3 billion in 2023, then soared by 154.87% to $2.3 billion in 2024, then increased by 19.62% to $2.8 billion in 2025.
  • Business Quant data shows Revenue for OSCR at $2.8 billion in Q4 2025, $3.1 billion in Q3 2025, and $2.8 billion in Q2 2025.